An anticoagulant with no risk of bleeding developed between Geneva and Sydney

Scientists at the University of Geneva, in collaboration with the University of Sydney in Australia, have developed a new anticoagulant whose action can be rapidly halted thanks to an associated "antidote". Together, they enable better management of the risk of bleeding complications.